Press Announcements > FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

Press Announcements > FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

07/03/2017 01:17 PM EDT

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.